Metro Healthcare Berhad
Metro Healthcare Berhad, together with its subsidiaries, provides hospital and related services in Malaysia. It offers inpatient, outpatient, and ambulatory care services. The company also provides fertility services, such as assisted reproductive technology and specialized fertility procedures; and obstetrics services that include pre-pregnancy screening and counselling, family planning counsell… Read more
Metro Healthcare Berhad (0329) - Net Assets
Latest net assets as of December 2025: RM74.99 Million MYR
Based on the latest financial reports, Metro Healthcare Berhad (0329) has net assets worth RM74.99 Million MYR as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM92.35 Million) and total liabilities (RM17.36 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM74.99 Million |
| % of Total Assets | 81.21% |
| Annual Growth Rate | 21.57% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 43.24 |
Metro Healthcare Berhad - Net Assets Trend (2021–2025)
This chart illustrates how Metro Healthcare Berhad's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Metro Healthcare Berhad (2021–2025)
The table below shows the annual net assets of Metro Healthcare Berhad from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | RM74.99 Million | -0.83% |
| 2024-12-31 | RM75.62 Million | +102.32% |
| 2023-12-31 | RM37.38 Million | +6.04% |
| 2022-12-31 | RM35.25 Million | +2.65% |
| 2021-12-31 | RM34.34 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Metro Healthcare Berhad's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 18.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM18.70 Million | 24.94% |
| Other Components | RM56.29 Million | 75.06% |
| Total Equity | RM74.99 Million | 100.00% |
Metro Healthcare Berhad Competitors by Market Cap
The table below lists competitors of Metro Healthcare Berhad ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TPC Plus Bhd
KLSE:7176
|
$4.10 Million |
|
Canstar Resources Inc
PINK:CSRNF
|
$4.10 Million |
|
5G Networks Ltd
AU:5GN
|
$4.10 Million |
|
Rotshtein
TA:ROTS
|
$4.10 Million |
|
DARI COUSPATE
BC:DARI-COUSPATE
|
$4.10 Million |
|
INNO-GENE SA ZY -10
F:WQ3
|
$4.10 Million |
|
Cohen Dev
TA:CDEV
|
$4.10 Million |
|
KZTA
F:KZTA
|
$4.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Metro Healthcare Berhad's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 75,618,514 to 74,993,000, a change of -625,514 (-0.8%).
- Net income of 5,736,000 contributed positively to equity growth.
- Dividend payments of 6,363,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM5.74 Million | +7.65% |
| Dividends Paid | RM6.36 Million | -8.48% |
| Other Changes | RM1.49K | +0.0% |
| Total Change | RM- | -0.83% |
Book Value vs Market Value Analysis
This analysis compares Metro Healthcare Berhad's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.81x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.15x to 2.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | RM0.04 | RM0.22 | x |
| 2022-12-31 | RM0.04 | RM0.22 | x |
| 2023-12-31 | RM0.05 | RM0.22 | x |
| 2024-12-31 | RM0.08 | RM0.22 | x |
| 2025-12-31 | RM0.08 | RM0.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Metro Healthcare Berhad utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.65%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.38%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 1.23x
- Recent ROE (7.65%) is below the historical average (14.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 27.49% | 22.33% | 0.84x | 1.46x | RM6.00 Million |
| 2022 | 14.23% | 12.45% | 0.78x | 1.46x | RM1.49 Million |
| 2023 | 16.72% | 13.98% | 0.75x | 1.60x | RM2.51 Million |
| 2024 | 6.03% | 9.38% | 0.51x | 1.27x | RM-3.00 Million |
| 2025 | 7.65% | 11.38% | 0.55x | 1.23x | RM-1.76 Million |
Industry Comparison
This section compares Metro Healthcare Berhad's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,607,284,020
- Average return on equity (ROE) among peers: 30.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Metro Healthcare Berhad (0329) | RM74.99 Million | 27.49% | 0.23x | $4.10 Million |
| TMC Life Sciences Bhd (0101) | $48.97 Million | 18.72% | 0.24x | $32.96 Million |
| Optimax Holdings Sdn Bhd (0222) | $20.79 Million | 21.38% | 1.70x | $17.14 Million |
| Cengild Medical Berhad (0243) | $9.79 Million | 40.37% | 3.81x | $11.79 Million |
| DC HEALTHCARE HOLDINGS BERHAD (0283) | $4.75 Million | 39.98% | 2.55x | $5.67 Million |
| ALPHA (0303) | $54.55 Million | 97.60% | 0.76x | $70.68 Million |
| PMCK Berhad (0363) | $81.09 Million | 13.23% | 0.33x | $421.93 |
| IHH Healthcare Bhd (5225) | $25.90 Billion | 3.74% | 0.50x | $6.11 Billion |
| KPJ Healthcare Bhd (5878) | $2.74 Billion | 12.92% | 1.70x | $1.99 Billion |